Search company, investor...

Predict your next investment

Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
iqvia.com

See what CB Insights has to offer

Investments

7

Partners & Customers

10

Service Providers

1

About IQVIA

IQVIA provides analytics, technology solutions, and clinical research services to the life sciences industry. It helps the healthcare industry in drug development, ensures product quality and safety, improves commercial effectiveness, gets the right treatments to patients, improves access to and delivery of healthcare, and gets health outcomes. The company was founded in 1982 and is based in Durham, North Carolina.

Headquarters Location

4820 Emperor Blvd

Durham, North Carolina, 27703,

United States

866-267-4479

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing IQVIA

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find IQVIA in 1 Expert Collection, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

IQVIA Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

IQVIA Rank

Latest IQVIA News

AstraZeneca leads winners at Reuters Pharma Awards 2022

Nov 30, 2022

November 30, 2022 On Thursday, 17 November, Reuters opened the doors for its first European awards ceremony. The event brought together some of the best and brightest minds working across pharma and healthcare to celebrate those setting the bar higher and broadening the possibilities for pharma by showing what can be achieved. The grand architecture of 8 Northumberland Avenue’s decadent Victorian ballroom provided a unique backdrop to recognise and reward the key innovations and innovators in 12 value-based categories covering every aspect of the pharma value chain. Winners were selected by a panel of 30 judges, comprised of both industry experts and patients, who reviewed more than 700 entry submissions before selecting 75 finalists to reach the prize-giving stage. “With 700 nominations, our judges – a mixture of patients and health professionals – deliberated hard for many hours, finally settling on just 12 winners, each exemplifying the very best work in pharma. By ‘best’, we mean not just internal successes, but real impact on patients, carers, and international health systems,” said Josh Bramwell, sector head, pharma at Reuters Events. “This is the night I feel most proud to work in this industry – the range and quality of solutions shows we can make a real difference.” And the award goes to… The standout winner for Reuter’s inaugural European Pharma awards was AstraZeneca (AZ), which took home two trophies. Kicking off the event with a bang, AZ scooped up the first award of the afternoon, the Most Valuable Digital Patient Engagement Award, sponsored by Within3, for its 360º COVID-19 Vaccine Confidence Building Programme. The company would not have to wait long to receive its second trophy, the Driving Health Equity Award, for AstraZeneca International’s work on an AI collaboration for the early detection of lung cancer. While AZ was the only organisation to take home two prizes, it was certainly in good company. The next award, Delivering Inclusive Trials, went to Moderna for its work in improving diversity and inclusion in clinical trials. Patients and patient care were key talking points throughout the event, with multiple categories dedicated to showcasing patient-focused developments. The first of these, the Patient Champion Award – Pharma, sponsored by pharmaphorum, was presented to Astellas for taking patient centricity from idea to organising principle in under three years, with a specific mention given to Anthony Yanni, senior vice president and global head of patient centricity at Astellas. Also spotlighted was IQVIA ‘s Dr Clare Moloney, a health psychologist single handily changing the patient support landscape, who was awarded the 2022 Patient Champion Award – Patient Advocate. Digital tools and technologies were also championed, with Smith+Nephew awarded Most Valuable HCP Initiative for WOUND COMPASS Clinical Support App Revolution: TIME for Change, and Takeda taking home the trophy for Most Valuable Medical Education/Awareness Initiative Award for FULL ADHD – a mobile game designed to increase awareness of adult ADHD. MSD continued this theme, receiving the Most Valuable Collaboration Award for its Social Isolation Management Programme (SIMP), while Biogen took home the trophy for Most Valuable Digital Therapy. As the event neared its end, attention turned towards personalised medicine, as ATMPS took to the stage to collect the award for Most Valuable Data & Insights Initiative. The penultimate award for Health Entrepreneur was presented to FabRx for 3D printing for personalised medicines. Finally, to close the awards portion of the event, Janssen’s SafeReturns Program was announced as the 2022 winner of the Sustainability Award. Full list of winners: Driving Health Equity Award: AstraZeneca for AI collaboration for early detection of lung cancer by AstraZeneca International Delivering Inclusive Trials Award: Moderna for Moderna’s inclusive clinical trials Patient Champion Award – Pharma: Astellas for taking patient centricity from idea to organising principle in under three years: Anthony Yanni at Astellas Patient Champion Award – Patient Advocate: IQVIA for Dr Clare Moloney: a health psychologist single handily changing the patient support landscape Most Valuable Digital Patient Engagement Award: AstraZeneca for 360º Covid-19 Vaccine Confidence Building Programme by AstraZeneca International Most Valuable HCP Initiative Award: Smith+Nephew for WOUND COMPASS Clinical Support App Revolution: TIME for Change Most Valuable Medical Education/Awareness Initiative Award: Takeda for FULL ADHD Most Valuable Collaboration Award: MSD for SIMP – Social Isolation Management Programme Most Valuable Digital Therapy Award: Biogen for Care+: A New Patient Service Most Valuable Data & Insights Initiative Award: ATMPS for Hataali Health Entrepreneur Award: FabRx for 3D printing for personalised medicines Sustainability Award: Janssen for the SafeReturns Program – Janssen’s Innovation for Sustainability Don't miss your daily pharmaphorum news.

IQVIA Investments

7 Investments

IQVIA has made 7 investments. Their latest investment was in Kairos as part of their Secondary Market on March 3, 2021.

CBI Logo

IQVIA Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2021

Secondary Market

Kairos

Yes

1

12/18/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

10/4/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/1/2019

Series B

Subscribe to see more

$99M

Subscribe to see more

10

7/19/2018

Series A - II

Subscribe to see more

Subscribe to see more

10

Date

3/1/2021

12/18/2019

10/4/2019

7/1/2019

7/19/2018

Round

Secondary Market

Series C

Series A

Series B

Series A - II

Company

Kairos

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

IQVIA Acquisitions

11 Acquisitions

IQVIA acquired 11 companies. Their latest acquisition was Lasso Marketing on October 26, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/26/2022

$99M

Acquired

1

8/8/2022

$99M

Acquired

8

4/1/2021

$99M

Acquired

2

2/12/2019

Subscribe to see more

$99M

Subscribe to see more

10

5/1/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/26/2022

8/8/2022

4/1/2021

2/12/2019

5/1/2018

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

8

2

10

10

IQVIA Partners & Customers

10 Partners and customers

IQVIA has 10 strategic partners and customers. IQVIA recently partnered with Coeptis Therapeutics on November 11, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

11/22/2022

Partner

United States

07:00 ET Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development Program

`` Given this tremendous opportunity , Coeptis Therapeutics Holdings , Inc. is now moving full-force to initiate a first-in-human clinical program to investigate SNAP-CAR , and we are excited to partner IQVIA to begin the development process .

1

11/10/2022

Partner

IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel

RESEARCH TRIANGLE PARK , N.C. -- -- IQVIA ™ , a leading global provider of advanced analytics , technology solutions and clinical research services to the life sciences industry , today announced a long-term collaboration with Clalit Health Services , the largest health services organization in Israel , to launch the first Prime Site in the country .

2

9/28/2022

Client

India

IQVIA announces partnership with Dr Reddy’s Laboratories for CRM Solution for India Field Force

`` We look forward to our partnership with Dr Reddy 's Laboratories and to deploying our best-in-class CRM solution that creates precisely targeted and personalized HCP interactions , leading to improved business outcomes , '' said Amit Mookim , Managing Director , South Asia , IQVIA .

1

7/28/2022

Partner

Malaysia

Subscribe to see more

Subscribe to see more

10

6/1/2022

Partner

United States

Subscribe to see more

Subscribe to see more

0

Date

11/22/2022

11/10/2022

9/28/2022

7/28/2022

6/1/2022

Type

Partner

Partner

Client

Partner

Partner

Business Partner

Country

United States

India

Malaysia

United States

News Snippet

07:00 ET Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development Program

`` Given this tremendous opportunity , Coeptis Therapeutics Holdings , Inc. is now moving full-force to initiate a first-in-human clinical program to investigate SNAP-CAR , and we are excited to partner IQVIA to begin the development process .

IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel

RESEARCH TRIANGLE PARK , N.C. -- -- IQVIA ™ , a leading global provider of advanced analytics , technology solutions and clinical research services to the life sciences industry , today announced a long-term collaboration with Clalit Health Services , the largest health services organization in Israel , to launch the first Prime Site in the country .

IQVIA announces partnership with Dr Reddy’s Laboratories for CRM Solution for India Field Force

`` We look forward to our partnership with Dr Reddy 's Laboratories and to deploying our best-in-class CRM solution that creates precisely targeted and personalized HCP interactions , leading to improved business outcomes , '' said Amit Mookim , Managing Director , South Asia , IQVIA .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

0

IQVIA Service Providers

1 Service Provider

IQVIA has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Merger

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Merger

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

IQVIA Team

64 Team Members

IQVIA has 64 team members, including , .

Name

Work History

Title

Status

Jacob Kobber Petersen

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Jacob Kobber Petersen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare IQVIA to Competitors

T
TriNetX

TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. It combines real-time access to longitudinal clinical data with analytics. The company was founded in 2013 and is based in Cambridge, Massachusetts.

Syapse Logo
Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Holmusk Logo
Holmusk

Holmusk is a data science and digital therapeutics company with a global presence that is dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Holmusk's proprietary technology powers data-driven medicine that leverages analytic and digital tools to address the unmet need in healthcare and pharma-life science.

Verana Health Logo
Verana Health

Verana Health assembles clinical databases in medicine to empower physicians and accelerate research for patients. The databases produce drug lifecycle and medical practice insights.

LifeOmic Logo
LifeOmic

LifeOmic is the developer of a secure cloud service for the long-term storage, retrieval, analysis, and clinical use of information central to patient care. Its PHC platform integrates and indexes disparate sources including genomic, clinical, imaging, and population data. All of this data is added to a searchable and flexible repository for each patient to deliver precision treatments and accelerate research. LifeOmic's LIFE mobile apps use the Precision Health Clous to empower individuals to be more involved in and take action on their personal health and wellness goals.

ConcertAI Logo
ConcertAI

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.